[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367862-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367862-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ongoing-genome-doubling-shapes-evolvability-and-immunity-in-ovarian-cancer","Ongoing genome doubling shapes - evolvability and immunity in ovarian cancer","","Whole-genome doubling (WGD) is a common hallmark of human cancers linked to tumor progression, drug resistance, and metastasis. Single-cell whole-genome sequencing of 70 high-grade serous ovarian cancer samples from 41 patients (30,260 tumor genomes) shows near-universal evidence that WGD continues as an ongoing mutational process. WGD increases cell diversity and chromosomal missegregation, driving micronucleation. A mutation-based timing method, doubleTime, reveals early fixation with diversification, parallel WGD events on copy-number diversity, and late WGD in small clones. Matched single-cell RNA sequencing and immunofluorescence show inflammatory cGAS-STING activation from ongoing instability mainly in WGD-low tumors, whereas WGD-high tumors show dysregulated cell cycle, STING1 repression, and immunosuppressive states.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ongoing-genome-doubling-shapes-evolvability-and-immunity-in-ovarian-cancer/367862/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ongoing-genome-doubling-shapes-evolvability-and-immunity-in-ovarian-cancer/367862.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study show about whole-genome doubling (WGD) in high-grade serous ovarian cancer?","Question",{"text":63,"@type":64},"WGD is observed as a near-universal, ongoing mutational process during tumor evolution rather than a single past event.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is WGD timing analyzed in the study?",{"text":68,"@type":64},"The authors develop a mutation-based WGD timing method called doubleTime to delineate distinct evolutionary modes, including early fixation with diversification and late WGD in small clones.",{"name":70,"@type":61,"acceptedAnswer":71},"How do WGD-low and WGD-high tumors differ in immune signaling?",{"text":72,"@type":64},"WGD-low tumors show cGAS-STING activation and inflammatory signaling driven by ongoing chromosomal instability, while WGD-high tumors exhibit cell-cycle dysregulation, STING1 repression, and immunosuppressive phenotypic states.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367862,1790195374,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Ongoing genome doubling shapes  \nevolvability and immunity in ovarian cancer  \n\n| [https://doi.org/10.1038/s41586-025-09240-3](https://doi.org/10.1038/s41586-025-09240-3)\u003Cbr>Received: 11 July 2024 Accepted: 4 June 2025 Published online: 16 July 2025 Open access\u003Cbr> Check for updates | Andrew McPherson1,2,25✉, Ignacio Vázquez-García1,2,3,22,23,25, Matthew A. Myers1,2,25,\u003Cbr>Duaa H. Al-Rawi1,2,4,25, Matthew Zatzman1,2,25, Adam C. Weiner1,2,5, Samuel Freeman1,2, Neeman Mohibullah6, Gryte Satas1,2, Marc J. Williams1,2, Nicholas Ceglia1,2,\u003Cbr>Danguolė Norkūnaitė1,2, Allen W. Zhang7, Jun Li8,9, Jamie L. P. Lim1, Michelle Wu1,2, Seongmin Choi1,2, Eliyahu Havasov1,2, Diljot Grewal1,2, Hongyu Shi1, Minsoo Kim1,2,5, Roland F. Schwarz10,11, Tom Kaufmann11,12, Khanh Ngoc Dinh3,13, Florian Uhlitz1,2, Julie Tran1,2, Yushi Wu6, Ruchi Patel6, Satish Ramakrishnan6, DooA Kim6, Justin Clarke6, Hunter Green14, Emily Ali1,2,14, Melody DiBona8,9, Nancy Varice15, Ritika Kundra16, Vance Broach15,\u003Cbr>Ginger J. Gardner15, Kara Long Roche15, Yukio Sonoda15, Oliver Zivanovic15,17, Sarah H. Kim15, Rachel N. Grisham4,18, Ying L. Liu4,18, Agnes Viale16, Nicole Rusk1,2, Yulia Lakhman18,19,\u003Cbr>Lora H. Ellenson14, Simon Tavaré3, Samuel Aparicio20, Dennis S. Chi15, Carol Aghajanian4, Nadeem R. Abu-Rustum15,21, Claire F. Friedman4,18, Dmitriy Zamarin4,24, Britta Weigelt14, Samuel F. Bakhoum8,9 & Sohrab P. Shah1,2 ✉\u003Cbr>Whole-genome doubling (WGD) is a common feature of human cancersand is linked to tumour progression, drug resistance, and metastasis1–6. Here we examine the impact ofWGDon somatic evolution and immune evasion at single-cell resolution inpatient tumours. Using single-cell whole-genome sequencing, we analysed 70 highgrade serous ovarian cancer samples from 41 patients (30,260 tumour genomes) and observed near-ubiquitous evidence that WGDisan ongoing mutational process. WGD was associated with increased cell–cell diversity and higher rates of chromosomal missegregation and consequent micronucleation. We developed a mutation-based WGD timing method called doubleTime to delineate specific modes by which WGD can drive tumour evolution, including early fixation followed by considerable diversification, multiple parallel WGD events on a pre-existing background of copynumber diversity, and evolutionarily late WGDin small clonesand individual cells. Furthermore, using matched single-cell RNA sequencing and high-resolution immunofluorescence microscopy, we found that inflammatory signalling and cGASSTING pathway activation result from ongoing chromosomal instability, but this is restricted to predominantly diploid tumours (WGD-low). By contrast, predominantly WGD tumours (WGD-high), despite increased missegregation, exhibited cell-cycledysregulation, STING1 repression, and immunosuppressive phenotypic states. Together, these findings establish WGDasan ongoing mutational process that promotes evolvability and dysregulated immunity in high-grade serous ovarian cancer. |  |\n| --- | --- | --- |\n| Whole-genome doubling (WGD) is found in more than 30% of solid can- |  | phenotypes, and the tumour microenvironment remains poorly under- |\n| cersand leads to increased rates of metastasis, drug resistance and poor |  | stood, being limited in part by bulk whole-genome sequencing (WGS) |\n| therapeutic outcomes1–5. Often observedona background ofTP53 muta- |  | approaches that do not allow the identification ofWGD subpopula- |\n| tion, WGD leads to increased chromosomal instability (CIN) and karyo- |  | tions. Crucially, reports from in vitro and patient-derived xenograft |\n| typic diversification4,7,8. Errors in chromosome segregation often lead to |  | models have demonstrated that the temporal and evolutionary dynam- |\n| cytokinesis failure and the generation of polyploid cells9, indicating that |  | ics ofWGD can be captured at single-cell resolution12,13. We therefore |\n| WGD maybe an active process during tumour evolution7. Furthermore, |  | sought to use single-cel","cbCaicnDD7XPcZYc","https://ap.wps.com/l/cbCaicnDD7XPcZYc","pdf",58212289,39,"English","# Background and study aim\n# Methods: single-cell WGS and matched profiling\n# Key findings on WGD dynamics\n## Timing and evolutionary modes (doubleTime)\n# Link to immunity and cGAS-STING pathway\n## Differences between WGD-low and WGD-high","[{\"question\":\"What does the study show about whole-genome doubling (WGD) in high-grade serous ovarian cancer?\",\"answer\":\"WGD is observed as a near-universal, ongoing mutational process during tumor evolution rather than a single past event.\"},{\"question\":\"How is WGD timing analyzed in the study?\",\"answer\":\"The authors develop a mutation-based WGD timing method called doubleTime to delineate distinct evolutionary modes, including early fixation with diversification and late WGD in small clones.\"},{\"question\":\"How do WGD-low and WGD-high tumors differ in immune signaling?\",\"answer\":\"WGD-low tumors show cGAS-STING activation and inflammatory signaling driven by ongoing chromosomal instability, while WGD-high tumors exhibit cell-cycle dysregulation, STING1 repression, and immunosuppressive phenotypic states.\"}]","Ongoing genome doubling shapes - evolvability and immunity in ovarian cancer | PDF",1790173023,98,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed69f694e5a428a03293def60e0dd134.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51ff9d24410357d96f1f8c8341dab5a2.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16aa565735ba7ca37aa9a38934b33316.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcfd5fad57cd8259f25e6bfa0ebb7555.webp",980,1301]